These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37599632)

  • 21. Innate and Adaptive Immune Responses in Chronic HCV Infection.
    Dustin LB
    Curr Drug Targets; 2017; 18(7):826-843. PubMed ID: 26302811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunopathogenesis of Liver Injury During Hepatitis C Virus Infection.
    Irshad M; Gupta P; Irshad K
    Viral Immunol; 2019 Apr; 32(3):112-120. PubMed ID: 30817236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global analysis of a mathematical model for Hepatitis C virus transmissions.
    Shi R; Cui Y
    Virus Res; 2016 Jun; 217():8-17. PubMed ID: 26940946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of innate and adaptive immune responses in controlling hepatitis C virus infection.
    Thimme R; Binder M; Bartenschlager R
    FEMS Microbiol Rev; 2012 May; 36(3):663-83. PubMed ID: 22142141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of chemokines in hepatitis C virus-mediated liver disease.
    Brass A; Brenndörfer ED
    Int J Mol Sci; 2014 Mar; 15(3):4747-79. PubMed ID: 24646914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability and Hopf Bifurcation in a Delayed HIV Infection Model with General Incidence Rate and Immune Impairment.
    Li F; Ma W; Jiang Z; Li D
    Comput Math Methods Med; 2015; 2015():206205. PubMed ID: 26413141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of a within-host HIV/HTLV-I co-infection model with immunity.
    Elaiw AM; AlShamrani NH
    Virus Res; 2021 Apr; 295():198204. PubMed ID: 33157165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of an HTLV/HIV dual infection model with diffusion.
    Elaiw AM; AlShamrani NH
    Math Biosci Eng; 2021 Oct; 18(6):9430-9473. PubMed ID: 34814353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innate and adaptive immunity shape circulating HCV strains.
    Gaudieri S; Lucas M
    Nat Genet; 2017 Apr; 49(5):657-658. PubMed ID: 28442794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability and bifurcation analysis of an HIV-1 infection model with a general incidence and CTL immune response.
    Ma X; Zhang Y; Chen Y
    J Biol Dyn; 2021 Dec; 15(1):367-394. PubMed ID: 34251981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global dynamics of an age-dependent multiscale hepatitis C virus model.
    Lan Y; Li Y; Zheng D
    J Math Biol; 2022 Aug; 85(3):21. PubMed ID: 35972543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innate and adaptive immune responses in HCV infections.
    Heim MH; Thimme R
    J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mathematical Analysis and Clinical Implications of an HIV Model with Adaptive Immunity.
    Danane J; Allali K
    Comput Math Methods Med; 2019; 2019():7673212. PubMed ID: 31827588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Qualitative behaviour of a stochastic hepatitis C epidemic model in cellular level.
    Lestari D; Megawati NY; Susyanto N; Adi-Kusumo F
    Math Biosci Eng; 2022 Jan; 19(2):1515-1535. PubMed ID: 35135215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunity and hepatitis C: a review.
    Terilli RR; Cox AL
    Curr HIV/AIDS Rep; 2013 Mar; 10(1):51-8. PubMed ID: 23180007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global stability analysis of humoral immunity virus dynamics model including latently infected cells.
    Elaiw AM
    J Biol Dyn; 2015; 9():215-28. PubMed ID: 26145479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A time since onset of injection model for hepatitis C spread amongst injecting drug users.
    Corson S; Greenhalgh D; Hutchinson SJ
    J Math Biol; 2013 Mar; 66(4-5):935-78. PubMed ID: 22926752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of a delayed SARS-CoV-2 reactivation model with logistic growth and adaptive immune response.
    Elaiw AM; Alsaedi AJ; Hobiny AD; Aly S
    Physica A; 2023 Apr; 616():128604. PubMed ID: 36909816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A model of HIV-1 infection with two time delays: mathematical analysis and comparison with patient data.
    Pawelek KA; Liu S; Pahlevani F; Rong L
    Math Biosci; 2012 Jan; 235(1):98-109. PubMed ID: 22108296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.